Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tegoprazan vs Vonoprazan for H. pylori Eradication
NCT07242456Phase 3Recruiting
- Sponsor
- Hangzhou First People's Hospital
- Start
- Feb 2025
- Primary completion
- Nov 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of tegoprazan in Helicobacter pylori infection (2 arms), sponsored by Hangzhou First People's Hospital. Primary endpoint: Helicobacter pylori Eradication Rate. Started Feb 2025; status: recruiting.
02
Drugs
tegoprazan
03
Conditions
Helicobacter pylori infection
Beyond the preview
Go deeper on NCT07242456.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07242456.